Nitric oxide prevents axonal degeneration by inducing HIF-1–dependent expression of erythropoietin

Nitric oxide (NO) is a signaling molecule that can trigger adaptive (physiological) or maladaptive (pathological) responses to stress stimuli in a context-dependent manner. We have previously reported that NO may signal axonal injury to neighboring glial cells. In this study, we show that mice deficient in neuronal nitric oxide synthase (nNOS−/−) are more vulnerable than WT mice to toxin-induced peripheral neuropathy. The administration of NO donors to primary dorsal root ganglion cultures prevents axonal degeneration induced by acrylamide in a dose-dependent manner. We demonstrate that NO-induced axonal protection is dependent on hypoxia-inducible factor (HIF)-1–mediated transcription of erythropoietin (EPO) within glial (Schwann) cells present in the cultures. Transduction of Schwann cells with adenovirus AdCA5 encoding a constitutively active form of HIF-1α results in amelioration of acrylamide-induced axonal degeneration in an EPO-dependent manner. Mice that are partially deficient in HIF-1α (HIF-1α+/−) are also more susceptible than WT littermates to toxic neuropathy. Our results indicate that NO→HIF-1→EPO signaling represents an adaptive mechanism that protects against axonal degeneration.

[1]  J. McArthur,et al.  Schwann cell chemokine receptors mediate HIV‐1 gp120 toxicity to sensory neurons , 2003, Annals of neurology.

[2]  A. Hoffmann,et al.  Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis. , 2010, Genes & development.

[3]  P. Ghezzi,et al.  Erythropoietin both protects from and reverses experimental diabetic neuropathy. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. Epstein,et al.  Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia. , 2010, Blood.

[5]  D. Kleinfeld,et al.  The glial cell response is an essential component of hypoxia-induced erythropoiesis in mice. , 2009, The Journal of clinical investigation.

[6]  P. Lewczuk,et al.  Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[7]  A. Hoke,et al.  Erythropoietin is neuroprotective in models of HIV sensory neuropathy , 2004, Neuroscience Letters.

[8]  M. Gassmann,et al.  Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. , 1998, Genes & development.

[9]  J. Merrill,et al.  The role of nitric oxide in multiple sclerosis , 1997, Journal of Molecular Medicine.

[10]  A. Höke,et al.  Neuroprotection in the PNS: erythropoietin and immunophilin ligands. , 2005, Annals of the New York Academy of Sciences.

[11]  D. Price,et al.  Slow axonal transport in acrylamide neuropathy: different abnormalities produced by single-dose and continuous administration , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[12]  Stuart A. Lipton,et al.  Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades , 2001, Nature.

[13]  T. Dawson,et al.  Deadly Conversations: Nuclear-Mitochondrial Cross-Talk , 2004, Journal of bioenergetics and biomembranes.

[14]  A. Hoke,et al.  FK506 is neuroprotective in a model of antiretroviral toxic neuropathy , 2003, Annals of neurology.

[15]  U. Dirnagl,et al.  Hypoxia-Induced Stroke Tolerance in the Mouse Is Mediated by Erythropoietin , 2003, Stroke.

[16]  U. Dirnagl,et al.  Erythropoietin Is a Paracrine Mediator of Ischemic Tolerance in the Brain: Evidence from an In Vitro Model , 2002, The Journal of Neuroscience.

[17]  G. Semenza,et al.  Hearts From Rodents Exposed to Intermittent Hypoxia or Erythropoietin Are Protected Against Ischemia‐Reperfusion Injury , 2003, Circulation.

[18]  Majid Ali Oxygen Homeostasis , 2005 .

[19]  T. Honda,et al.  Nitric oxide synthase expressions in rat dorsal root ganglion after a hind limb tourniquet , 2003, Neuroreport.

[20]  G. Semenza,et al.  Induction of hypoxia‐inducible factor‐1 (HIF‐1) and its target genes following focal ischaemia in rat brain , 1999, The European journal of neuroscience.

[21]  John T. Finn,et al.  Axonal Self-Destruction and Neurodegeneration , 2002, Science.

[22]  R. Lehmann,et al.  Hypoxia-Inducible Factor-1 Is Central to Cardioprotection: A New Paradigm for Ischemic Preconditioning , 2008, Circulation.

[23]  G. Semenza,et al.  Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. , 1993, Blood.

[24]  J. Barnes,et al.  Peripheral Neuropathy in Rats Produced by Acrylamide , 1966, British journal of industrial medicine.

[25]  Kenneth Maiese,et al.  Erythropoietin Is a Novel Vascular Protectant Through Activation of Akt1 and Mitochondrial Modulation of Cysteine Proteases , 2002, Circulation.

[26]  P. Narasimhan,et al.  Neuroprotection by Hypoxic Preconditioning Involves Oxidative Stress-Mediated Expression of Hypoxia-Inducible Factor and Erythropoietin , 2005, Stroke.

[27]  G. Semenza,et al.  Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[28]  E. Lehning,et al.  Acrylamide-induced distal axon degeneration: a proposed mechanism of action. , 1994, Neurotoxicology.

[29]  G. Semenza,et al.  Protection from Oxidative Stress–Induced Apoptosis in Cortical Neuronal Cultures by Iron Chelators Is Associated with Enhanced DNA Binding of Hypoxia-Inducible Factor-1 and ATF-1/CREB and Increased Expression of Glycolytic Enzymes, p21waf1/cip1, and Erythropoietin , 1999, The Journal of Neuroscience.

[30]  Kiichi Hirota,et al.  Cell Type–Specific Regulation of Angiogenic Growth Factor Gene Expression and Induction of Angiogenesis in Nonischemic Tissue by a Constitutively Active Form of Hypoxia-Inducible Factor 1 , 2003, Circulation research.

[31]  W. Kaelin,et al.  Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. , 2008, Molecular cell.

[32]  K. Boje Nitric oxide neurotoxicity in neurodegenerative diseases. , 2004, Frontiers in bioscience : a journal and virtual library.

[33]  R. Myers,et al.  Erythropoietin and erythropoietin receptors in the peripheral nervous system: changes after nerve injury , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  G. Semenza,et al.  Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1 alpha. , 2008, Cardiovascular research.

[35]  M. Raff,et al.  Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve , 1979, Brain Research.

[36]  R. Ratan,et al.  Translation of Ischemic Preconditioning to the Patient: Prolyl Hydroxylase Inhibition and Hypoxia Inducible Factor-1 as Novel Targets for Stroke Therapy , 2004, Stroke.

[37]  T. Beaty,et al.  Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha. , 1999, The Journal of clinical investigation.

[38]  A. Cerami,et al.  Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[39]  J. Fandrey,et al.  Oxygen-sensing under the influence of nitric oxide. , 2010, Cellular signalling.

[40]  A. Hoke,et al.  A novel endogenous erythropoietin mediated pathway prevents axonal degeneration , 2004, Annals of neurology.